AI assistant
Sending…
Solid Biosciences Inc. — Director's Dealing 2021
Jan 27, 2021
33003_dirs_2021-01-27_70d89a98-d798-4383-8ed7-d44c5d0f980f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2021-01-25
Reporting Person: Ganot Ilan (Director, CEO & President)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-25 | Employee Stock Option (Right to Buy) | $6.80 | A | 438000 | Acquired | 2031-01-25 | Common Stock (438000) | Direct |
| 2021-01-25 | Employee Stock Option (Right to Buy) | $6.80 | A | 8100 | Acquired | 2031-01-25 | Common Stock (8100) | Indirect |
Footnotes
F1: This option was granted on January 25, 2021 and vests in four equal annual installments on the anniversary of the grant date.
More from Solid Biosciences Inc.
Interim / Quarterly Report
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 23
Board/Management Information
2026
Apr 10
Capital/Financing Update
2026
Mar 19
Annual Report
2026
Mar 19
Major Shareholding Notification
2026
Mar 17
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19